Ad Alert


The FDA sent a warning letter to Algaen Corporation over the marketing of their dietary supplement Algaberry earlier this year. The FDA determined that Algaen was advertising Algaberry as an unapproved drug with claims such as:

• “The nutraceutical and pharmacological effects AlgaBerry™ were historically described as anti-inflammatory … control of hypertension … ”

• “Modern studies have suggested that AlgaBerry™ may contain a broad range of compounds that have anti-microbial, anti-viral, anti-tumor, or anti-cancer activity.”

• “Nostoc was mostly described to treat a variety of medical conditions, including inflammatory, nyctalopia (night blindness) … chronic fatigue

• ” … Nostoc contain[s] … active compounds … that exert nutraceutical and pharmacological effects, which range from anti-microbial, anti-viral to anti-tumor, anti-cancer … activities.”

• “Nostoc also contains a large amount of phycobiliproteins, which have been known to … have strong … anti-inflammatory activities.”

Algaen has since altered their marketing of AlgaBerry, though the product is still for sale.

Consumers should, as always, be wary of over the top health claims, especially for products unapproved by the FDA. For more on supplements, click here.

Our Ad Alerts are not just about false and deceptive marketing issues, but may also be about ads that, although not necessarily deceptive, should be viewed with caution. Ad Alerts can also be about single issues and may not include a comprehensive list of all marketing issues relating to the brand discussed.

You Might Be Interested In

UNBS CBD Gummies

Ad Alert

UNBS CBD Gummies

Spam email leads to a fake endorsement from Dr. Oz, among other celebrities.